Jul 25, 2024, 00:35
Rodrigo Sánchez-Bayona: Our editorial on CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:
“How have CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer? Delighted to share this editorial in Annals of Oncology, coauthored with Mafalda Oliveira.”
Source: Rodrigo Sánchez-Bayona/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 12:53
Jan 16, 2025, 12:46
Jan 16, 2025, 12:32
Jan 16, 2025, 12:30
Jan 16, 2025, 12:30
Jan 16, 2025, 12:26
Jan 16, 2025, 10:18
Jan 16, 2025, 10:17
Jan 16, 2025, 10:13
Jan 16, 2025, 10:07
Jan 16, 2025, 10:01